AgingResearch.NewsJoin free

Optimal-massive intervention

Optimal-massive intervention has been studied in 1 paper since 2026: 1 trial in people; 1 in the past year. The newest story, Nov 11, 2026: “Enhanced swallowing care had some early benefits in older adults”.

Intervention

1 paper studies it6 findingsUpdated

1 new paper in 30 daysSee all 1 papers on optimal-massive intervention

At a glance

The findings reach people, from one lab or study. 1 lab.

“better QoL in the OMI group at 1 month (p=0.047)”
Evaluation of the effectiveness of an Optimal-Massive Intervention in older hospitalized patients with Oropharyngeal DysphagiaFrontiers in nutrition2026doi:10.3389/fnut.2026.2044387

None of its findings points the other way.

Humans: a single group. Cells, worms or flies and mice: nothing yet.

C, W, M, H: cells, worms or flies, mice, humans. Dark: independent labs found the same change there. Light: one lab or one study. Outline: nothing yet.

  • 1 lab
  • Human trial1

Studies in people

1 study gave optimal-massive intervention to people and measured what changed.

What changedDesignPeopleSource

up: Improves quality of life

down: Decreases frailty

up: Improves oral health

Randomized trial1 month600 people70 years or olderOlder adults; Hospitalized patients with oropharyngeal dysphagiaFrontiers in nutrition, Nov 11, 2026

What did studies of optimal-massive intervention find?

6

Studies of optimal-massive intervention measured 6 outcomes, among them respiratory tract infection, hospital readmissions and mortality.

Respiratory tract infection

no changein humans1

1 study

  1. Optimal-massive intervention showed no clear effect on respiratory tract infection in humans (7.7 vs 10.7 per 100 patients over 6 months (OMI vs MMI)).

    “respiratory infections (7.7/100 patients-6 months vs. 10.7/100 patients-6 months) did not differ between OMI and MMI.”

    Human trialHospitalized patients with oropharyngeal dysphagia; compared with minimal massive intervention6 monthsn = 600

    Enhanced swallowing care had some early benefits in older adults

    Frontiers in nutrition

More on Respiratory tract infection

Hospital readmissions

no changein humans1

1 study

  1. Optimal-massive intervention showed no clear effect on hospital readmissions in humans (30.0 vs 34.0 per 100 patients over 6 months (OMI vs MMI)).

    “Six-month mortality (16.0% vs 15.0%), readmissions (30.0/100 patients-6 months vs. 34.0/100 patients-6 months) and respiratory infections (7.7/100 patients-6 months vs. 10.7/100 patients-6 months) did not differ between OMI and MMI.”

    Human trialHospitalized patients with oropharyngeal dysphagia; compared with minimal massive intervention6 monthsn = 600

    Enhanced swallowing care had some early benefits in older adults

    Frontiers in nutrition

Mortality

no changein humans1

1 study

  1. Optimal-massive intervention showed no clear effect on mortality in humans (16.0% vs 15.0% (OMI vs MMI)).

    “Six-month mortality (16.0% vs 15.0%), readmissions (30.0/100 patients-6 months vs. 34.0/100 patients-6 months) and respiratory infections (7.7/100 patients-6 months vs. 10.7/100 patients-6 months) did not differ between OMI and MMI.”

    Human trialHospitalized patients with oropharyngeal dysphagia; compared with minimal massive intervention6 monthsn = 600

    Enhanced swallowing care had some early benefits in older adults

    Frontiers in nutrition

Oral health

upin humans1

1 study

  1. Optimal-massive intervention improves oral health in humans.

    “OMI showed some additional benefits at earlier follow-up time points, particularly in QoL, OH, frailty, and adherence to treatment”

    Human trialHospitalized patients with oropharyngeal dysphagia; compared with minimal massive interventionEarlier follow-up time pointsn = 600

    Enhanced swallowing care had some early benefits in older adults

    Frontiers in nutrition

Frailty

downin humans1

1 study

  1. Optimal-massive intervention decreases frailty in humans.

    “OMI showed some additional benefits at earlier follow-up time points, particularly in QoL, OH, frailty, and adherence to treatment”

    Human trialHospitalized patients with oropharyngeal dysphagia; compared with minimal massive interventionEarlier follow-up time pointsn = 600

    Enhanced swallowing care had some early benefits in older adults

    Frontiers in nutrition

Quality of life

upin humans1

1 study

  1. Optimal-massive intervention improves quality of life in humans.

    “better QoL in the OMI group at 1 month (p=0.047)”

    Human trialHospitalized patients with oropharyngeal dysphagia; compared with minimal massive intervention1 monthn = 600

    Enhanced swallowing care had some early benefits in older adults

    Frontiers in nutrition

Latest

Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 0Nov 2026: 11 paper in 12 months
Frontiers in Nutrition

Enhanced swallowing care had some early benefits in older adults

In a randomized trial, 600 hospitalized adults with swallowing difficulties received one of two care programs; most differences were no longer evident at six months.In a randomized trial, 600 hospitalized adults with swallowing difficulties received one of two care programs; most differences were no longer evident at six months.

Accepted, not yet published: randomized trial · 600 peopleInterventions
Paper

Related